FDA Inspection 1087542 — Transtracheal Systems, Inc.

Transtracheal Systems, Inc. — FEI 1721097

The FDA completed an inspection of Transtracheal Systems, Inc. on April 26, 2019 in Englewood, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 26, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Compliance: Devices
Location
Englewood, CO (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
315921 CFR 820.184DHR content
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
333121 CFR 820.181DMR - not or inadequately maintained
343321 CFR 820.75(c)Process changes - review, evaluation and revalidation
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation